Semax

Semax Research Peptide

Semax is a synthetic heptapeptide derived from the ACTH(4-10) region and is widely investigated in experimental neuroscience and neuropharmacology.

The peptide sequence is:

Met-Glu-His-Phe-Pro-Gly-Pro

Semax research has focused on its relationship with brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), TrkB signaling, neuronal survival, neuroplasticity, learning and memory pathways.

Experimental studies have demonstrated changes in BDNF and TrkB expression following Semax exposure, providing a basis for continued investigation into its neurotrophic and neuroprotective mechanisms.

Pure Axis Peptides offers Semax as a research-use peptide for qualified laboratory and scientific investigations.

What Is Semax?

Semax is a synthetic seven-amino-acid peptide structurally related to the N-terminal fragment 4-10 of adrenocorticotropic hormone.

Unlike full-length ACTH, Semax is designed as a short peptide analogue for investigating biological pathways associated with the ACTH-derived sequence.

Research has particularly focused on the central nervous system and the peptide’s potential effects on:

• Neurotrophic signaling
• BDNF expression
• NGF expression
• TrkB signaling
• Neuronal survival
• Synaptic plasticity
• Learning and memory
• Neuroprotection
• Stress-related signaling

A major research interest is understanding how this short peptide can influence neurotrophic signaling without reproducing the classical hormonal activity of full-length ACTH.

Semax Sequence

The canonical Semax sequence is:

Met-Glu-His-Phe-Pro-Gly-Pro

This seven-residue sequence is derived from the ACTH(4-10) region with a Pro-Gly-Pro extension.

Sequence-specific characterization is particularly important when working with Semax because modified derivatives, including N-acetylated and amidated variants, are distinct molecular entities and should not automatically be treated as interchangeable with native Semax.

Semax and ACTH(4-10)

Semax is closely related to the ACTH(4-10) peptide fragment.

ACTH is a much larger pituitary hormone involved in the hypothalamic-pituitary-adrenal axis, while Semax is a short synthetic peptide derived from the ACTH(4-10) region.

This distinction is important for research:

ACTH → endocrine hormone

ACTH(4-10) → peptide fragment

Semax → synthetic ACTH(4-10)-related heptapeptide

Semax research has focused primarily on neurological and neurotrophic effects rather than the classical adrenal effects associated with full-length ACTH.

Semax and BDNF

One of the most important research pathways associated with Semax is brain-derived neurotrophic factor (BDNF).

BDNF is a neurotrophin involved in:

• Neuronal survival
• Synaptic plasticity
• Learning
• Memory
• Neuronal differentiation
• Adaptive neural signaling

Experimental research found that Semax increased BDNF protein levels in the rat basal forebrain after intranasal administration. Researchers also identified specific, reversible binding of Semax in basal-forebrain membrane preparations.

This makes Semax BDNF research one of the strongest scientific and SEO subtopics for the product.

Semax and TrkB Signaling

BDNF produces many of its biological effects through TrkB, a receptor tyrosine kinase expressed throughout the nervous system.

Research in rats has reported that Semax increased:

• BDNF protein
• BDNF mRNA
• TrkB mRNA
• TrkB phosphorylation

in the hippocampus following administration.

This provides a mechanistic basis for investigating Semax within the:

Semax → BDNF → TrkB → neuronal signaling

research pathway.

Semax and NGF

Nerve growth factor (NGF) is another important neurotrophin involved in neuronal development, maintenance and signaling.

Experimental studies have reported changes in NGF gene expression following Semax exposure.

Research in rat glial-cell cultures observed changes in both BDNF and NGF mRNA, with the strongest increases occurring shortly after peptide exposure.

This makes Semax relevant to experimental studies of:

• Neurotrophin expression
• Neuronal survival
• Neuroplasticity
• Glial signaling
• Neuroregeneration pathways

Semax and Neuroplasticity

Neuroplasticity describes the ability of the nervous system to modify neuronal connections and functional responses.

Because BDNF and TrkB signaling are closely associated with synaptic plasticity, Semax has been investigated as a potential modulator of neuroplasticity-related pathways.

Experimental studies have connected Semax exposure with changes in hippocampal BDNF/TrkB signaling and behavioral measures related to learning.

For research purposes, Semax may therefore be studied in relation to:

• Synaptic plasticity
• Neuronal adaptation
• Learning-associated signaling
• Memory pathways
• Neurotrophic regulation

Semax and Neuronal Survival

Neurotrophic factors such as BDNF and NGF play important roles in neuronal survival.

Semax has been investigated experimentally in models examining neuronal stress and survival.

Research has reported changes in neurotrophin gene expression following Semax treatment, providing a potential mechanism for further investigation into neuronal resilience.

These findings should be interpreted as experimental evidence, rather than evidence that Semax is an established neuroprotective treatment in humans.

Semax and Cognitive Research

Semax has been studied in experimental models involving:

• Learning
• Memory
• Attention
• Behavioral conditioning
• Neurotrophic signaling

One experimental study reported changes in hippocampal BDNF and TrkB signaling alongside behavioral effects associated with conditioned avoidance learning.

This makes Semax cognitive research an important long-tail SEO opportunity.

Appropriate scientific terminology includes:

• Cognitive neuroscience
• Learning and memory research
• Neuroplasticity research
• Neurotrophic signaling
• Behavioral neuroscience

Semax and Memory Research

Memory formation involves complex interactions between neuronal networks, synaptic plasticity and neurotrophic signaling.

BDNF/TrkB pathways are particularly relevant to memory-related neurobiology.

Experimental Semax research has investigated changes in hippocampal BDNF/TrkB signaling and learning-related behavioral outcomes.

Potential research endpoints include:

• Memory formation
• Learning behavior
• Synaptic plasticity
• BDNF expression
• TrkB activation
• Hippocampal signaling

Semax and Attention Research

Semax has also been investigated in experimental research involving attention and behavioral performance.

The scientific literature has described effects on selective attention and memory, although the strength and generalizability of human evidence remain considerably more limited than the volume of promotional claims surrounding the peptide.

For SEO, the safer and more scientifically defensible positioning is:

“Semax attention and cognitive research”

rather than promising improved concentration or productivity.

Semax and Hippocampal Research

The hippocampus plays a central role in learning and memory.

Experimental research has investigated Semax-related changes in hippocampal:

• BDNF
• TrkB
• Neurotrophin gene expression
• Neural signaling

One study reported increases in BDNF protein and TrkB phosphorylation following Semax exposure in rats.

This makes Semax particularly relevant to hippocampal neuroscience research.

Semax and Glial Cells

Glial cells are important regulators of neuronal health and signaling.

Research has examined Semax effects in cultured glial cells, finding changes in expression of neurotrophic-factor genes including BDNF and NGF.

This provides another research pathway:

Semax → glial signaling → neurotrophin expression → neuronal environment

Potential applications include:

• Glial biology
• Neurotrophin research
• Cell signaling
• Neuronal-support mechanisms
• Neuroprotective research

Semax and Neurotrophic Signaling

The term neurotrophic refers to factors and signaling pathways that support neuronal growth, differentiation, maintenance and function.

Semax research has repeatedly focused on neurotrophic pathways, especially:

• BDNF
• TrkB
• NGF
• Neurotrophin gene expression

Experimental studies have provided evidence for changes in these pathways following Semax exposure.

This makes Semax neurotrophic research a strong topical keyword cluster.

Semax and Gene Expression

Semax has been investigated for its ability to influence expression of neurotrophic genes.

Experimental work has reported changes in:

• BDNF gene expression
• NGF gene expression
• TrkB expression

following peptide administration or cellular exposure.

This makes Semax suitable for research examining:

• Gene-expression responses
• Neurotrophin regulation
• Transcriptional signaling
• Temporal gene-expression changes

Semax and Neuroprotection Research

Neuroprotection is another major area of Semax investigation.

Experimental studies have explored whether Semax influences neuronal survival and neurotrophic pathways under stressful conditions.

Research has associated Semax with neurotrophin expression and neuronal survival mechanisms, although evidence varies substantially by model and experimental context.

The product page should therefore use “neuroprotection research” rather than claiming that Semax definitively protects the human brain.

Semax and Cerebral Ischemia Research

Semax has been investigated in research related to cerebral ischemia and neurological injury.

Its experimental interest in this area is partly associated with its effects on neurotrophic signaling and neuronal survival pathways.

For SEO, useful related topics include:

• Semax cerebral ischemia research
• Semax neuroprotection research
• Neurotrophic peptide research
• Brain injury research
• Neuronal survival research

These should remain clearly framed as research topics rather than treatment claims.

Semax and Neurological Research

Semax provides an experimental model for investigating several areas of neuroscience, including:

• Neurotrophic signaling
• Cognitive neuroscience
• Memory biology
• Attention
• Neuroprotection
• Neuronal survival
• Gene expression
• Glial signaling
• Synaptic plasticity

Its relatively small molecular size also makes it useful for studying structure-function relationships in neuroactive peptides.

Semax and Peptide Pharmacology

Semax is an interesting example of how a small peptide derived from a larger endocrine hormone can acquire a distinct experimental pharmacological profile.

Research can examine:

• Peptide-receptor interactions
• Cellular signaling
• Neurotrophin regulation
• Tissue distribution
• Stability
• Structure-activity relationships

This makes Semax relevant to broader peptide pharmacology research.

Semax vs. N-Acetyl Semax Amidate

Native Semax and N-Acetyl Semax Amidate should not be treated as identical compounds.

Semax is the heptapeptide:

Met-Glu-His-Phe-Pro-Gly-Pro

N-Acetyl Semax Amidate incorporates chemical modifications at the peptide termini.

These modifications can alter:

• Chemical properties
• Stability
• Pharmacokinetics
• Biological activity
• Analytical characterization

Therefore, product pages should use the exact chemical identity supplied rather than combining the variants into a single generic “Semax” product.

Semax vs. Selank

Semax and Selank are both commonly categorized within experimental neuroactive peptide research, but they are structurally and biologically distinct.

Semax

• ACTH(4-10)-related heptapeptide
• Neurotrophic research
• BDNF/TrkB research
• Neuroprotection research

Selank

• Tuftsin-derived synthetic peptide
• Investigated primarily in neuroimmune and anxiolytic-related research
• Different sequence and biological pathways

Explore Selank for related neuroscience peptide research.

Semax and Selank Research Cluster

These two products provide an opportunity to build a broader nootropic and neuroscience peptide research cluster.

Internal content can connect:

Semax → BDNF → neuroplasticity → cognition

and

Selank → neuroimmune signaling → anxiety/stress research

A comparison article such as “Semax vs Selank: Understanding Two Experimental Neuroactive Peptides” can capture valuable long-tail searches while clearly explaining that the compounds are not interchangeable.

Semax Research Applications

Semax may be relevant to laboratory studies involving:

Neuroscience Research: Investigating peptide effects on the central nervous system.

BDNF Research: Studying brain-derived neurotrophic factor expression and signaling.

TrkB Research: Investigating BDNF receptor signaling.

NGF Research: Studying nerve growth factor expression.

Neuroplasticity Research: Investigating synaptic and neuronal adaptation.

Memory Research: Studying learning and memory pathways.

Attention Research: Investigating cognitive and behavioral signaling.

Neuroprotection Research: Examining neuronal survival mechanisms.

Hippocampal Research: Studying hippocampal neurotrophic signaling.

Glial Research: Investigating glial-cell responses.

Gene-Expression Research: Studying neurotrophin transcriptional regulation.

Peptide Pharmacology: Investigating neuroactive peptide mechanisms.

Semax Research Material

Researchers should verify the current Pure Axis Peptides product specification, peptide identity, sequence, molecular weight, purity, formulation, storage requirements and batch-specific certificate of analysis (COA) before laboratory use.

For standard Semax, the relevant peptide sequence is:

Met-Glu-His-Phe-Pro-Gly-Pro

Researchers should also distinguish native Semax from modified derivatives such as N-acetylated or amidated Semax variants.

Current Regulatory Context

Semax has a complex regulatory history across jurisdictions.

It has been used and studied clinically in Russia and other countries, but its regulatory status differs by country.

In July 2026, an FDA advisory committee voted to recommend Semax for inclusion on the U.S. pharmacy-compounding list. However, this was an advisory recommendation rather than FDA approval, and the FDA retains the final decision.

Pure Axis product content should therefore avoid implying that research-grade Semax is an FDA-approved drug or that the advisory vote establishes clinical efficacy.

Explore Related Research

Semax fits naturally into a broader neuroscience and neuroactive peptide research cluster.

Explore Selank for related neuroactive peptide research.

Explore Epitalon for additional experimental peptide research involving aging and cellular biology.

Browse the Peptides collection for additional research materials.

Visit Shop All Products for the complete Pure Axis Peptides catalog.

Research Use Only

Semax supplied by Pure Axis Peptides is intended strictly for laboratory and scientific research. It is not intended for human consumption, self-administration, diagnosis, treatment, cure, or prevention of any disease or medical condition. Experimental studies have investigated Semax in relation to neurotrophic signaling, BDNF, NGF, TrkB, learning, memory and neuroprotection, but these findings should not be interpreted as establishing the research-grade material as an approved treatment. Regulatory status varies by jurisdiction, and a 2026 FDA advisory recommendation regarding compounding should not be represented as FDA approval. Researchers should evaluate all materials according to their experimental requirements, product documentation and applicable laboratory procedures.

Internal Linking Recommendations

Primary Internal Links

• Selank → https://pureaxispeptides.com/product/selank/
• Epitalon → https://pureaxispeptides.com/product/epitalon/
• Peptides → https://pureaxispeptides.com/product-category/peptides/
• Shop All Products → https://pureaxispeptides.com/shop/

Verify the exact live WooCommerce URLs before publishing.

Recommended Internal-Link Anchors

Use varied contextual anchors such as:

• “Semax research peptide”
• “Semax research”
• “ACTH(4-10) analogue”
• “neuroactive peptide research”
• “BDNF research peptide”
• “neurotrophic peptide research”
• “neuroplasticity research”
• “cognitive neuroscience research”
• “neuroprotection research”
• “brain-derived neurotrophic factor research”
• “TrkB signaling research”
• “neuropharmacology research”

Recommended Site Architecture

Build a dedicated neuroscience peptide cluster:

Semax
→ ACTH(4-10)
→ BDNF
→ TrkB
→ NGF
→ Neuroplasticity
→ Learning & memory
→ Neuroprotection
→ Hippocampal signaling
→ Glial signaling
→ Selank
→ Epitalon

A strong supporting article would be:

“Semax vs Selank: Understanding Experimental Neuroactive Peptides”

Another valuable article would be:

“Semax and BDNF: Understanding Neurotrophic Signaling in Experimental Research”

These articles can distribute internal authority back to the Semax and related product pages.

External Scientific References

• PubMed — Semax, BDNF and basal forebrain:
  Semax and BDNF Protein Expression
• PubMed — Semax, BDNF and TrkB in hippocampus:
  Semax, BDNF and TrkB Expression
• PubMed — Semax and BDNF/NGF gene expression:
  Semax Effects on Neurotrophin Gene Expression
• PubMed — Semax and neurotrophin expression in glial cells:
  Semax-Induced BDNF and NGF Expression
• Current U.S. regulatory reporting:
  FDA Advisory Panel Recommendation on Semax

Product Tags

Semax, Semax Peptide, Semax Research, Semax Research Peptide, Semax Peptide Research, ACTH 4-10, ACTH(4-10), ACTH 4-10 Analogue, ACTH Fragment Research, Met-Glu-His-Phe-Pro-Gly-Pro, Neuroactive Peptide, Neuroactive Peptide Research, Neuroscience Research, Neuropharmacology, Neurotrophic Peptide, Neurotrophic Research, BDNF Research, Brain Derived Neurotrophic Factor, BDNF Signaling, TrkB Research, TrkB Signaling, NGF Research, Nerve Growth Factor, Neuroplasticity Research, Synaptic Plasticity, Cognitive Research, Cognitive Neuroscience, Memory Research, Learning Research, Attention Research, Hippocampal Research, Neuroprotection Research, Neuronal Survival, Glial Research, Neurotrophin Research, Gene Expression Research, Brain Research Peptide, Peptide Pharmacology, Experimental Peptide, Research Peptide, Laboratory Research